Clinical Trial Update: Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the addition of albiglutide to standard glucose-lowering therapies and its effect on major cardiovascular events in adults with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Albiglutide (albiglutide)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2019-03-06